MayoComplete Solid Tumor Panel: Kevin C. Halling, M.D., Ph.D.

(00:31):

Before we get started, Dr. Halling, could you provide us with a little bit about you and your background?

(01:11):

Would you like to give us a basic summary of this test?

(02:43):

So in talking about patients, can you tell us which patients should have this testing? And when it is typically performed?

(05:01):

Do you want to talk about some of the guidelines that were used to shape the genes included in this panel?

(05:36):

Can you tell us a bit about the alternative test options that are available and how they compare to this large panel?

(06:42):

So I know most other panels on the market assess for mutations and fusions. Is there a reason why our panel also looks at amplifications and are certain subset of the genes?

(07:29):

So do you want to talk about how this panel offers some benefits over other large panels in the market?

(08:46):

Let's talk a little bit about how the results of this test can be used in patient care.